6877 — Top Eminent Healthcare Income Statement
0.000.00%
- HK$319.23m
- HK$101.79m
- HK$86.49m
Annual income statement for Top Eminent Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.62 | 2.74 | 39.1 | 191 | 86.5 |
| Cost of Revenue | |||||
| Gross Profit | 2.66 | 2.11 | 6.65 | 36.5 | 31.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 85.2 | 51.4 | 49.9 | 177 | 73.9 |
| Operating Profit | -80.6 | -48.7 | -10.8 | 14.6 | 12.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -81.2 | -49 | -10.9 | 14.6 | 12.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -71.6 | -49 | -11 | 12.8 | 11.3 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -71.6 | -56.5 | -31.1 | 9.84 | 11.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -71.6 | -56.5 | -31.1 | 9.84 | 11.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.035 | -0.024 | -0.005 | 0.006 | 0.005 |